Literature DB >> 22715269

Cepacia syndrome in a cystic fibrosis patient colonised with Burkholderia multivorans.

Irfan Shafiq1, Marry P Carroll, Julia A Nightingale, Thomas V W Daniels.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22715269      PMCID： PMC3062378          DOI： 10.1136/bcr.08.2010.3296

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  1 in total

1.  Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

Authors:  A M Jones; M E Dodd; J R W Govan; V Barcus; C J Doherty; J Morris; A K Webb
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139
  1 in total
  4 in total

1.  Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Elise T Zeiser; Nozomi Ohuchi; Maria F Mojica; Julian A Gatta; Monica Falleni; Delfina Tosi; Elisa Borghi; Marisa L Winkler; Brigid M Wilson; John J LiPuma; Michiyoshi Nukaga; Robert A Bonomo
Journal:  ACS Infect Dis       Date:  2017-03-30       Impact factor: 5.084

2.  Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Elise T Zeiser; Julian A Gatta; John J LiPuma; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Cepacia Syndrome in a Non-Cystic Fibrosis Patient.

Authors:  Naomi Hauser; Jose Orsini
Journal:  Case Rep Infect Dis       Date:  2015-08-18

4.  Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis.

Authors:  Silvia Lai; Sandro Mazzaferro; Anna Paola Mitterhofer; Enea Bonci; Paolo Giangreco Marotta; Francesco Pelligra; Manuel Murciano; Camilla Celani; Patrizia Troiani; Giuseppe Cimino; Paolo Palange
Journal:  J Transl Med       Date:  2019-11-25       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.